Who owns TURN THERAPEUTICS INC?
- Ticker: TTRX
- CUSIP Number: 90021w105
Tip: Access positions for across all investors
Analyze quarterly positions in Turn Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Turn Therapeutics stock
Who bought or sold TURN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DDFG | 71k | $226M | 35% | Mar 2026 |
|
| Millennium Management | 70k | $223k | -27% | Mar 2026 |
|
| Wellington Shields & Co | 66k | $210k | 0% | Mar 2026 |
|
| Vanguard Capital Management | 50k | $158k | 100% | Mar 2026 |
|
| Vanguard Group | 30k | $119k | 100% | Dec 2025 |
|
| XTX Topco | 25k | $99k | 100% | Dec 2025 |
|
| Brown Brothers Harriman & Co. | 24k | $76k | 0% | Mar 2026 |
|
| HighTower Advisors | 20k | $63k | 0% | Mar 2026 |
|
| RVW Wealth | 18k | $58k | 0% | Mar 2026 |
|
| Geode Capital Management | 17k | $55k | 0% | Mar 2026 |
|
| Miracle Mile Advisors | 16k | $51k | 0% | Mar 2026 |
|
| Tamar Securities | 15k | $59k | 100% | Dec 2025 |
|
| Bank of America Corporation | 14k | $45k | 100% | Mar 2026 |
|
| LPL Financial | 13k | $43k | 2% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 13k | $40k | 100% | Mar 2026 |
|
| Hodges Capital Management | 10k | $32k | 0% | Mar 2026 |
|
| Morgan Stanley | 10k | $32k | 0% | Mar 2026 |
|
| Ronald Blue Trust | 1.1k | $3.6k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 1.0k | $3.2k | 0% | Mar 2026 |
|
| UBS Group | 400.00 | $1.3k | 100% | Mar 2026 |
|
| Pflug Koory | 170.00 | $544.000000 | 0% | Mar 2026 |
|
| Tower Research Capital | 137.00 | $539.999200 | 100% | Dec 2025 |
|
Who sold out of Turn Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 21k | $83k |
| Jane Street | Dec 2025 | 17k | $68k |